SNDK Outlier Hits 864.86 Percent as Verification Ongoing

Congressional purchases continue delivering standout results after their public release according to fresh trade filings. Several positions have now posted triple digit returns calculated strictly from disclosure dates when any investor could have reviewed the filings. These returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed.

Leading the group is Lisa McClain's SNDK buy disclosed November 21 2025. This position is an outlier we are still verifying rather than a finalized figure showing a current return of 864.86 percent. Ro Khanna's CCG purchase disclosed February 6 2026 is likewise an outlier we are still verifying with a return of 517.28 percent. Khanna's MRNA buy disclosed January 6 2026 represents another outlier we are still verifying that has returned 513.49 percent.

Verified trades show similar strength. Lisa McClain's CIEN purchase disclosed August 13 2025 has returned 373.09 percent. Tim Moore's TZA buy disclosed July 9 2025 sits at a 316.91 percent return while Scott H. Peters' KSS purchase disclosed May 16 2025 has gained 258.77 percent. The trades span technology communication services healthcare and consumer cyclical sectors with most positions sized between one thousand and fifteen thousand dollars except for Peters' larger KSS stake.

Days held range from 287 to 642 across the filings and current alpha remains elevated for each name. The bipartisan mix of Republican and Democratic lawmakers involved highlights how these patterns appear across party lines. While the data shows clear outperformance after the filings entered the public domain no inference is drawn here about information flow or intent. Market observers will continue monitoring whether similar patterns emerge in future disclosures.

This is data analysis, not financial advice.